Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Gut-Brain Axis

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...

Functions of the Gut Microbiota

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...

Microbiota of the Large Intestine

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...

Introduction to the Human Microbiota

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...

The Oral Microbiota

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...

Microbiota of the Stomach and Small Intestine

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

DNA methylation-based immune cell profiling in mouse blood using MouseRS-CMD.

Genome biology·2026

Same author

Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2.

Pathogens & immunity·2024

Same author

The Effect of Lung Resection for NSCLC on Circulating Immune Cells: A Pilot Study.

Current oncology (Toronto, Ont.)·2023

Same author

Evolution of antibody immunity following Omicron BA.1 breakthrough infection.

Nature communications·2023

Same author

Evolution of antibody immunity following Omicron BA.1 breakthrough infection.

bioRxiv : the preprint server for biology·2022

Same author

Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation·2021

Search research articles

Related Experiment Video

Updated: Apr 15, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

The gut microbiome in multiple sclerosis.

Daniel W Mielcarz¹, Lloyd H Kasper

¹Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, 1 Medical Center Drive, Lebanon, NH, 03756, USA, Daniel.W.Mielcarz@dartmouth.edu.

Current Treatment Options in Neurology

|April 7, 2015

Summary

This summary is machine-generated.

The gut microbiome, comprising trillions of bacteria, significantly impacts immune system development and is linked to various diseases. Research suggests its modulation may offer a promising treatment for demyelinating diseases like multiple sclerosis (MS).

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method

Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method

Published on: May 2, 2022

Related Experiment Videos

Last Updated: Apr 15, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method

Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method

Published on: May 2, 2022

Area of Science:

Microbiology
Immunology
Neurology

Background:

The human gut microbiome consists of thousands of bacterial species, with significant individual variations.
The gut microbiome plays a crucial role in immune system development and maintenance.
Alterations in gut microbiota composition are linked to diseases such as obesity, inflammatory bowel disease, and cardiovascular disease.

Purpose of the Study:

To explore the role of the gut microbiome in demyelinating diseases.
To investigate the potential of modulating gut microbiota for therapeutic benefit in multiple sclerosis (MS).

Main Methods:

Review of existing studies on gut microbiome composition and its effects on immune function.
Analysis of animal models demonstrating the microbiome's influence on demyelinating disease progression.
Examination of risk factors for MS (diet, vitamin D, smoking, alcohol) and their impact on gut microbiota.

Main Results:

Animal studies show the gut microbiome significantly influences demyelinating disease progression, with modulation affecting symptom severity.
Factors like diet, vitamin D, smoking, and alcohol intake can alter gut microbiota composition.
Preliminary clinical trials in MS patients are exploring gut microbiota modulation.

Conclusions:

The gut microbiome is implicated in the development and progression of demyelinating diseases.
Modulating the gut microbiota presents a potential avenue for novel, lower-risk therapeutic strategies in MS treatment.